Discover 928 paid clinical trials in Portland, Oregon. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 928
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
for
Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma,
Location: Portland OR, Eugene OR, Calgary, Los Angeles CA,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07221149
Phase 2, Phase 3, Recruiting
A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)
for
Solid Tumors, Neoplasms
Location: Portland OR, Seattle WA, Santa Rosa CA,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18+
Code: NCT06431594
Phase 1, Recruiting
Study of AVZO-021 in Patients With Advanced Solid Tumors
for
Advanced Solid Tumor, HR+/HER2- Breast Cancer,
Location: Portland OR, New Haven CT, Tampa FL, Cleveland OH,
Sponsor: Avenzo Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05867251
Phase 1, Phase 2, Recruiting
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
for
Focal Onset Seizures
Location: Portland OR, Boise ID, Los Angeles CA, Orange CA,
Sponsor: Xenon Pharmaceuticals Inc.
Sex: All
Age: 18+
Code: NCT05716100
Phase 3, Recruiting
IGNITE: Study of Tirabrutinib vs Rituximab and Temozolomide for Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL)
for
Relapsed/Refractory Primary Central Nervous System Lymphoma
Location: Portland OR, Seattle WA, Fullerton CA, Orange CA,
Sponsor: Ono Pharmaceutical Co., Ltd.
Sex: All
Age: 18+
Code: NCT07104032
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
for
Relapsing Multiple Sclerosis
Location: Portland OR, Vancouver, Edmonton, Las Vegas NV,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 40 - 70
Code: NCT06846281
Phase 3, Recruiting
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
for
Relapsed Hematologic Malignancy,
Location: Portland OR, Seattle WA, Salt Lake City UT,
Sponsor: Curis, Inc.
Sex: All
Age: 18+
Code: NCT03328078
Phase 1, Phase 2, Recruiting
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
for
Migraine
Location: Portland OR, Tacoma WA, Everett WA, Meridian ID,
Sponsor: AbbVie
Sex: All
Age: 6 - 17
Code: NCT05125302
Phase 3, Recruiting
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
for
Acute Treatment of Migraine
Location: Portland OR, Bellevue WA, Seattle WA, Walnut Creek CA,
Sponsor: Pfizer
Sex: All
Age: 6 - 17
Code: NCT04743141
Phase 3, Recruiting
Two Year Developmental Follow-up for PREMOD2 Trial (Premature Infants Receiving Milking or Delayed Cord Clamping)
for
Neurodevelopmental Abnormality
Location: Portland OR, Salt Lake City UT, Edmonton,
Sponsor: Sharp HealthCare
Sex: All
Age: 1 - 3
Code: NCT03476980
Recruiting
Treatment With Endovascular Intervention for STroke Patients With Existing Disability
for
Stroke, Stroke, Acute, Stroke, Ischemic
Location: Portland OR, Seattle WA, Palo Alto CA,
Sponsor: University of Cincinnati
Sex: All
Age: 18+
Code: NCT05911568
Recruiting
MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions
for
In-Stent Restenosis, Cardiovascular Diseases,
Location: Portland OR, Los Angeles CA, Gilbert AZ, Minneapolis MN,
Sponsor: Concept Medical Inc.
Sex: All
Age: 18 - 70+
Code: NCT05908331
Recruiting
FORWARD CAD IDE Study
for
Coronary Arterial Disease (CAD)
Location: Portland OR, Seattle WA, Bellevue WA, San Francisco CA,
Sponsor: Shockwave Medical, Inc.
Sex: All
Age: 18+
Code: NCT06662500
Recruiting
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
for
Intracerebral Hemorrhage
Location: Portland OR, Vancouver, Sacramento CA, San Francisco CA,
Sponsor: Joseph Broderick, MD
Sex: All
Age: 18 - 70+
Code: NCT07227246
Phase 3, Recruiting
Global Multicenter Registry on Transcatheter TRIcuspid Valve RePLACEment
for
Tricuspid Regurgitation
Location: Portland OR, Vancouver, Phoenix AZ, Wichita KS,
Sponsor: Montefiore Medical Center
Sex: All
Age: 18+
Code: NCT06033274
Recruiting
AGENT DCB STANCE: Safety and Effectiveness Study of AGENT Drug-Coated Balloon Compared to Standard of Care Percutaneous Coronary Intervention (PCI) Treatment for de Novo Coronary Lesions
for
Coronary Arterial Disease (CAD),
Location: Portland OR, Bellevue WA, San Francisco CA, Stanford CA,
Sponsor: Boston Scientific Corporation
Sex: All
Age: 18+
Code: NCT06959524
Recruiting
Machine Learning Prediction of Possible Central Line Associated Blood Stream Infections and Rate of Reduction
for
Central Line Associated Blood Stream Infections (CLABSI)
Location: Portland OR, Olympia WA, Seattle WA, Edmonds WA,
Sponsor: Swedish Medical Center
Sex: All
Age: 18+
Code: NCT07108660
Recruiting
Strategy for Improving Stroke Treatment Response
for
Ischemic Stroke
Location: Portland OR, Los Angeles CA, La Jolla CA, San Diego CA,